Can the Thoracic Replace the Conventional Radiography for the Diagnosis of Acute Pneumonia in Children?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-01

Study Completion Date

2016-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Thoracic ultrasound is a safer and sensitive technique than conventional radiography because it detects less than 1 cm pneumonic consolidations and minimal pleural effusions. The main objective is to evaluate the efficacy of thoracic ultrasound performed by unskilled personnel in the emergency service prdiatricas to diagnose pneumonia in children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized Children

NCT06296693

Pneumonia Pneumonia, Viral Pneumonia, Bacterial

NOT_YET_RECRUITING NA

Severe Pneumonia Diagnostic in Pediatric Population by Lung Ultrasonography and Procalcitonin

NCT04217980

Pneumonia Childhood

COMPLETED NA

Assessment of Thoracic Echography for Pleuroparenchymatous Anomaly Diagnosis Complicating Bronchiolitis: BronchioIUS

NCT02890797

Bronchiolitis

TERMINATED NA

Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections

NCT05921526

Lower Respiratory Infection LRTI Pneumonia +1 more

UNKNOWN NA

Diagnostic Accuracy of Lung Ultrasound for Pneumonia Diagnosis in Children

NCT07331311

Pneumonia Childhood Pneumonia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diagnostic test evaluation.The sample collected sequentially until an exact size . Given the safety of the technique, which involves no risk to patient management and the possibility of generating a type II error by premature study discontinuation , we have no plans to make any interim analyzes .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Candidates patients chest X-ray with pneumonia

thoracic sonography CXR Clinical control 48h

Group Type OTHER

Thoracic ultrasound

Intervention Type OTHER

CXR

Intervention Type OTHER

Candidates patients chest X-ray without pneumonia

thoracic sonography CXR Clinical control 48h

Group Type OTHER

Thoracic ultrasound

Intervention Type OTHER

CXR

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracic ultrasound

Intervention Type OTHER

CXR

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* fever above 38 degrees
* tachypnea
* Difficulty breathing
* Side tip pain
* pathological auscultation

Exclusion Criteria

* \< 3 months\> 14 years
* Background of Prematurity
* Rewalizados imaging studies in the last 7 days
* Any chronic respiratory process
* congenital heart diseases
* hemodynamic instability
* Diagnosis of pneumonia in the last 3 months
* Refusal of relatives to participate in the study

Minimum Eligible Age

3 Months

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No